Product Overview

• 4-Amino-1,1-Diphosphonic Acid, widely identified across international active chemical compounding frameworks as Alendronic Intermediate Acid or derivatives of geminal bisphosphonate core series, is a highly specialized organophosphorus building block compound structure. Structurally, it features a terminal primary aliphatic amine chain bound directly to a geminal diphosphonic acid carbon core. ProCorBay International supplies premium technical-grade and formulation-grade 4-Amino-1,1-Diphosphonic Acid powder to global pharmaceutical active processing facilities, bone-metabolism contract research networks, and advanced chemical synthesis labs requiring exceptional structural validations.
• This compound is typically manufactured through the precise reaction of 4-aminobutyric acid (GABA) precursors with phosphorus trichloride (PCl₃) and concentrated phosphorous acid matrices under highly regulated chemical heating loops, followed by cold aqueous hydrolysis, pH adjustment, and evaporative crystallization. ProCorBay actively manages raw distribution channels with premier organophosphorus complexes to deliver material featuring ultra-low free orthophosphate impurities, zero heavy metal traces, and high active chemical essays.
• Within life sciences and metabolic therapeutic manufacturing, this bisphosphonic core acts as an indispensable regulatory key starting material. It functions as the direct regulatory structural predecessor for compounding mainstream bone-resorption inhibitors—most notably serving as the key synthetic block for compounding Alendronate Sodium. The geminal bisphosphonate architecture delivers high bone-mineral affinity profiles when converted into the finalized dosage salt configuration, helping developers target osteoclast enzyme paths cleanly. ProCorBay handles deep bulk inventory allocations to ensure reliable production continuity for global pharmaceutical plants.